| 摘要: |
| 骨关节炎(osteoarthritis,OA)是一种慢性退行性骨关节疾病,主要表现为关节部位的疼痛、肿大,严重影响患者的生活质量。目前临床用药选择有限,一线用药为非甾体抗炎药(NSAIDs)与皮质醇类药物,但只能提供短期的缓解效果,不能改变疾病进展。利用合成化学和生物学工具开发的基于工程化RNA为未来骨关节炎治疗提供了希望,这些疗法具有持久、有效的作用机制,可以专门针对病理的潜在驱动因素。本综述重点介绍了具有骨关节炎治疗潜力的基于RNA的新兴技术,包括用于基因沉默的siRNA,用于多基因调控的microRNA,用于基因补充的mRNA。总之,本文的目的在于揭示RNA相关技术可以为骨关节炎提供新的治疗手段。 |
| 关键词: 骨关节炎 RNA技术 siRNA microRNA mRNA 新型疗法 |
| DOI:10.13506/j.cnki.jpr.2025.11.009 |
| 基金项目:国家自然科学基金面上项目(No.32471004) |
|
出版日期:2025-11-25
|
|
| Research progress of osteoarthritis therapy based on RNA technology |
| GUO Yixuan1,2,LIN Ang1,2 |
| (1.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198,China;2.Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198,China) |
| Abstract: |
| Osteoarthritis (OA) is a chronic degenerative bone disease, mainly manifested by joint pain and swelling that , seriously affect the quality of life. At present, the clinical medication options are limited. The first-line drugs are non-steroidal anti-inflammatory drugs (NSAIDs) and cortisol-based drugs, but they can only provide short-term relief effects and cannot change the progression of the disease. Engineered RNA-based therapies developed using synthetic chemistry and biological tools offer hope for future osteoarthritis treatments. These therapies have long-lasting and effective mechanisms of action and can specifically target the underlying drivers of pathology. In this brief review, we focus on emerging RNA-based technologies with therapeutic potential for OA, including siRNA for gene silencing, microRNA for polygenic regulation, and mRNA for gene supplementation. In conclusion, the purpose of this article is to reveal that RNA-related technologies can provide new treatment methods for osteoarthritis. |
| Key words: Osteoarthritis RNA technology siRNA microRNA mRNA Novel therapeutics |